Carbamazepine Suspension
Product Images NDC 51672-4047

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 51672-4047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carbamazepine 01)

FDA Label Image

Principal Display Panel (100 mg Chewable Tablet Bottle Label)

This text describes the details and instructions for using NDC 51672-4041-2, which is a medication containing 100 mg carbamazepine in 500 chewable tablets. It also provides information on dosage, storage, and precautions to be taken while using the medication. The manufacturer and distributor information are also mentioned.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

This is a prescription medication called Carbamazepine that comes in the form of 1000 tablets, with each tablet containing 200mg of the active ingredient. The NDC number is 51672-4005-3. The medication should be stored in a dry place and protected from moisture. It should also be dispensed in a tight container with a guide provided to each patient. The manufacturer is Taro Pharmaceutical Industries Ltd located in Haifa Bay, Israel, and the distributor is Taro Pharmaceuticals USA, Inc located in Hawthorne, NY 10522. It is important to note that this medication is only available by prescription.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

This is a description of Carbamazepine, which comes in extended-release tablets. The NDC code is 51672-4123-1, and the container should be stored at room temperature. It is important not to crush or chew the tablets, and the usual dosage should be followed as directed by a healthcare provider. The medication is manufactured by Taro Pharmaceuticals USA. It is essential to keep this and all medications out of children's reach.*

FDA Label Image

Principal Display Panel (200 mg Extended-Release Tablet Bottle Label)

NDC number 51672-4124-1 is assigned to Carbamazepine Extended-Release tablets. Each tablet contains 200 mg carbamazepine. The medication guide should be provided to every patient. The tablets must be taken whole and never crushed or chewed. Carbamazepine Extended-Release Tablets should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] and protected from moisture. It should be kept in a tight container, out of the reach of children. The dosage information is available in the package insert. Taro Pharmaceuticals is the manufacturer and distributor of the tablets.*

FDA Label Image

Principal Display Panel (400 mg Extended-Release Tablet Bottle Label)

Carbamazepine is an extended-release medication that is available in tablet form with 400mg carbamazepine in each tablet. It is essential to swallow the tablets whole and not to crush or chew them. The medication guide must be given to the patient. It is available in a right container and should be stored at 20° to 25°C (68° to 77°F). The drug must be kept out of reach of children, and its prescription must be followed as per the package insert. It is produced by Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel, and is distributed by Taro Pharmaceuticals, USA, Inc. This is a prescription drug for patients.*

FDA Label Image

Principal Display Panel (100 mg/5 mL Bottle Label)

This is a medication guide for Carbamazepine USP, with a concentration of 100mg/5ml, in a container of 450ml capacity. It is necessary to shake the medication well before using it, and each 5ml contains 100mg carbamazepine USP. The accompanying medication guide must be provided to each patient. This medication should be kept out of reach of children and stored between 20-25 degrees Celsius (66-77 F) in a light-resistant container. The manufacturer is Tam Pharmaceutical Industries Ltd from Haifa Bay, Israel, and the distributor is Tro Pharmaceuticals S A, Inc. from Hawthorne. Further instruction is included on the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.